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In this article, we review the history and progress of a large multicenter research network per-
taining to emergency medical services for children. We describe the history, organization, infra-
structure, and research agenda of the Pediatric Emergency Care Applied Research Network (PE-
CARN), and highlight some of the important accomplishments since its inception. We also de-
scribe the network’s strategy to grow its research portfolio, train new investigators, and study 
how to translate new evidence into practice. This strategy ensures not only the sustainability of 
the network in the future, but the growth of research in emergency medical services for children 
in general.
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What is already known
The Pediatric Emergency Care Applied Research Network (PECARN) has a long-
standing record of successful multicenter research in emergency medical ser-
vices for children in the United States. Since its inception in 2001, numerous re-
search studies regarding the care of acutely ill and injured children have been 
performed and published.
What is new in the current study
We summarize the activities and accomplishments of the network since the 
last summary of its activities was published in 2006. During this time, PECARN 
has continued this record of productivity and innovation with increased em-
phasis on randomized controlled trials, use of the electronic health record, and 
translation of research into practice.  PECARN also has increased its focus on 
sustainability through development and mentoring of young investigators, and 
broadened the applicability of its work through additional international collab-
oration.
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INTRODUCTION
The Pediatric Emergency Care Applied Research Network (PECARN) 
is a research collaboration of pediatric emergency departments 
(EDs) across the United States focusing on the care of acutely ill 
and injured children. Recognizing the need to generate definitive 
evidence to inform the treatment of acutely ill and injured chil-
dren, PECARN was established in 2001.1 Led by experienced in-
vestigators with expertise in pediatric emergency care, and with 
the support and oversight of the Emergency Medical Services for 
Children (EMSC) program of the Health Resources and Services 
Administration (HRSA), PECARN is the first research network of 
pediatric EDs funded by the Federal Government of the USA. The 
network is committed to conducting high-quality research in all 
phases of emergency care in children, including prevention, pre-
hospital and ED treatment, and rehabilitation. PECARN leverages 
a combined population of more than one million children treated 
annually in 18 EDs throughout the USA to overcome many of the 
barriers inherent to pediatric emergency care research.
BACKGROUND 
Previously, the ability to generate scientific evidence regarding 
the optimal care of acutely ill and injured children in EDs was 
limited by several barriers.1,2 The rarity of adverse outcomes in 
many pediatric conditions makes it difficult, if not impossible, to 
enroll a sufficiently large patient population at a single center to 
achieve the necessary statistical power to answer pressing clini-
cal questions definitively. Additionally, it can be difficult to obtain 
high quality data when enrolling patients into research studies in 
busy EDs, as ED clinicians have multiple competing demands on 
their time. Obtaining informed consent from the patient’s family 
may be difficult under the stressful conditions of the ED, or even 
impossible if the patient’s guardian is absent or also injured. The 
results of research findings performed in tertiary care (research) 
centers may be difficult to generalize to community hospitals, 
where most acutely ill and injured children are cared for. Finally, 
translating research results into the daily practice of clinicians 
working in acute care settings can be challenging. The infrastruc-
ture of PECARN supports collaboration on large multicenter stud-
ies and the sharing of experiences and best practices with com-
Fig. 1. Pediatric Emergency Care Applied Research Network (PECARN) network structure. PI, principal investigator; HRSA, Health Resources and Services 
Administration; MCHB, Maternal Child Health Bureau; EMSC, Emergency Medical Services for Children.
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munities of physicians, thus overcoming many of the barriers to 
performing pediatric emergency care research and then translat-
ing it into practice. 
ORGANIZATION AND INFRASTRUCTURE
PECARN is composed of seven research node centers (RNCs), lo-
cated throughout the United States. Fig. 1 depicts the PECARN 
structure, and Fig. 2 illustrates the locations of current PECARN 
sites. Funding from the United States Federal Government is di-
rected to each RNC through the EMSC program, established un-
der HRSA, Maternal Child Health Bureau (MCHB). An indepen-
dent data coordinating center (DCC) is also funded by EMSC and 
works collaboratively with the RNCs. The principal investigators 
of the RNCs (the nodal principal investigator [PI]), the PI of the 
DCC, and a representative from the federal funding agency form 
PECARN’s executive committee.
 Six of the RNCs each coordinate and provide oversight of three 
academic children’s EDs, known as Hospital Emergency Depart-
ment Affiliates (HEDAs), for a total of 18 ED sites within the net-
work. The seventh RNC was recently established and coordinates 
three emergency medical services agencies, instead of EDs, in or-
der to focus on pre-hospital research. Each HEDA agrees formally 
to participate in any PECARN research study appropriate for its 
facility. 
 Members of the PECARN steering committee loosely include 
investigators and research coordinators from each HEDA, as well 
as DCC staff and research administrators from the RNCs. Only 
one representative from each HEDA and one representative from 
the DCC, however, comprise the PECARN steering committee vot-
ing membership, which acts as the primary governing body and 
arbitrator of the network. All nodal PIs are voting members of the 
steering committee, as is the PI of the DCC. One nodal PI also serves 
as the chair of the PECARN steering committee, a position that 
rotates every three years in order to share opportunities for lead-
ership and to ensure equity among the RNCs. Early in the devel-
opment of the network, the PECARN steering committee estab-
lished bylaws, which describe its structure and membership, its 
policies and procedures, and its code of ethics and conduct. 
 PECARN’s subcommittees were also established early in the 
network’s development to advise the steering committee and per-
form specific tasks for the network. These subcommittees have 
evolved over time, to serve the ever-changing needs of the net-
work. Currently, the four subcommittees are the:
•  Protocol Review and Development Subcommittee, which re-
views specific research concepts and protocols and makes rec-
ommendations to the investigators, with the goal of improving 
the science of each proposal.
•  Feasibility and Budget Subcommittee, which reviews research 
concepts and protocols specifically to ensure that the studies 
can practicably be performed in PECARN, that budgets are suf-
ficient to conduct the research and that funding is allocated 
appropriately.
•  Grant Writing and Publications Subcommittee, which collabo-
rates with investigators to help create study authorship plans, 
and reviews and critiques documents (grants, abstracts, pre-
sentations, manuscripts) prior to submission or presentation.
•  Quality Assurance and Safety Subcommittee, which reviews 
research concepts and protocols to ensure compliance with 
standards for protection of human subjects, and monitors on-
going research to ensure rigorous adherence to patient safety 
and study protocols.
 The funding provided by HRSA/MCHB/EMSC supports PECARN’s 
infrastructure as described above and also supports two in-per-
son meetings of the steering committee and one in-person meet-
ing of the PECARN executive committee per year. The steering 
committee conducts approximately three additional meetings per 
year via teleconference. Other ad hoc meetings and teleconfer-
ences are held throughout the year, typically to address short turn-
around requests for grant proposals from federal funding agen-
cies. Investigators and research coordinators also participate in 
research study-specific meetings and teleconferences on a rou-
tine or as-needed basis.
 Because funding for PECARN supports only its infrastructure 
costs, investigators who lead research studies that are approved/
endorsed by the steering committee must compete for and be 
awarded extramural research grant funding in order to perform 
multicenter studies through the network. The typical funding sour-
Fig. 2. Locations of current Pediatric Emergency Care Applied Research 
Network (PECARN) sites.
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ces for PECARN research include the National Institutes of Health, 
the Centers for Disease Control and Prevention, and the Agency 
for Healthcare Research and Quality, although the changing fund-
ing environment encourages the network to look creatively for 
diverse funding sources.
 Extramural research grant funding augments the research in-
frastructure at participating PECARN sites and also funds study-
related activities at the PECARN DCC. The PECARN DCC employs 
project managers and data managers, as well as both doctorate 
and masters-level statisticians in order to provide support and 
leadership of study design, coordination and statistical analysis 
for PECARN projects. The PECARN DCC acts as a central reposito-
ry of network data and maintains highly sophisticated systems 
for secure transfer of electronic data. The DCC also performs a 
variety of quality assurance and training activities on behalf of 
the network and its research studies.
RESEARCH AGENDA 
PECARN’s research priorities are guided by the network’s published 
research agenda, which the steering committee developed in 2002 
using the Nominal Group Process and Hanlon Process of Prioriti-
zation.3 Using this well-established and validated qualitative pro-
cess, steering committee members participated in facilitated dis-
cussions during which they identified high-priority research top-
ics in pediatric emergency care and ranked the topics in order of 
perceived importance. The committee then refined the list of re-
search priorities by taking into account each condition’s preva-
lence, its seriousness (i.e., morbidity and/or mortality of the con-
dition or the disruption it causes to society), and the practicality 
and feasibility of studying the condition in PECARN (including the 
potential for external funding). The resulting research priorities 
list (Table 1) serves to maintain our focus on topics of great im-
portance to emergency medical services for children. However, 
PECARN will diverge from the published agenda at times, for spe-
cific reasons. For example, we will study new pressing health is-
sues as they arise. Our success as a network is largely dependent 
on the desire and drive of individual investigators to have a re-
search concept approved by the PECARN steering committee and 
ultimately his/her ability to secure funding to conduct the project, 
whether or not the topic of study is on the research priority list.
SCIENTIFIC REVIEW PROCESS FOR  
CONCEPTS/PROTOCOLS 
One of the strengths of PECARN is the quality and scope of the 
research studies conducted. This strength may be credited in part 
to a robust and coordinated scientific review process where sub-
committees work on behalf of investigators and the steering com-
mittee to refine and improve research studies during their devel-
opment. 
 This process begins with a brief preliminary research concept, 
which is developed in conjunction with one of the PECARN nodes. 
This concept may come from a member of PECARN or from an 
investigator outside of PECARN; both are given equal consider-
ation and priority. The sponsoring node conducts an initial and 
comprehensive concept review and discussion with member in-
vestigators and may also invite specific content experts to partic-
ipate as appropriate. Typically, modifications to the research con-
cept occur during this step of the process. If the research concept 
is approved by the node and subsequently approved by represen-
tatives of EMSC, the investigator then presents the concept to 
the entire steering committee at either an in-person meeting or 
teleconference. After the presentation, the investigator fields ques-
tions from the steering committee. The steering committee will 
hold a closed discussion (without the investigator present), follow-
ed by a confidential vote to endorse or reject the research con-
cept. If the concept is endorsed by the steering committee, the 
investigator will use the steering committee’s formal feedback to 
improve and refine the research question and expand it into a full 
research protocol. This expanded protocol is the precursor to the 
grant application that the investigator will eventually submit for 
external funding. 
 The investigator typically develops the concept into a protocol 
in collaboration with the PECARN DCC, often in-person during a 
pre-arranged working session. The PECARN DCC will engage its 
Table 1. Pediatric Emergency Care Applied Research Network research 
priorities
  1. Respiratory illness/asthma
  2. Prediction rules for high stakes/low likelihood diseases
  3. Medication error reduction
  4. Injury prevention
  5. Urgency and acuity scaling
  6. Race, ethnic, class disparities in health
  7. Mental health
  8. Treatment of infectious diseases
  9. Best practices in patient care
10. Pain & anxiety management
11. Education/training outcomes
12. Development of treatment algorithms
13. Improvement in health outcomes for cardiac arrest
14. Practice protocols
15. Seizure management
16. Cervical spine immobilization
Special mention: prehospital research
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PI, biostatisticians and data managers to provide input into pro-
tocol development to the study PI, with consideration given to 
feasibility and statistical issues. After the initial protocol is devel-
oped, the PECARN subcommittees review the protocol and pro-
vide additional feedback to the investigator. After subcommittee 
feedback is incorporated by the study PI, the steering committee 
votes on the final protocol version. By reviewing and approving 
every research study conducted within the network, the PECARN 
steering committee ensures that each study meets established 
network research priorities and contains high-quality science, and 
is ultimately feasible for conduct in the network. This process also 
ensures that PECARN members are invested in a research study’s 
successful completion. Ultimately, this rigorous review process 
increases an investigator’s likelihood of obtaining external fund-
ing and of performing successful studies in the network. The sub-
stantial track record of high-quality research in the network is in 
large part a testament to the comprehensive, collaborative and 
diligent process of network study development, as well as to the 
drive and determination of individual investigators.
EVOLUTION OF PECARN RESEARCH AND 
DESCRIPTION OF RESEARCH STUDIES
As PECARN evolves, the research studies we perform as a network 
also grow and evolve. PECARN’s initial research studies were fund-
ed by core infrastructure funding only and descriptive in nature. 
Subsequently, we received external funding for and performed 
several large observational cohort studies. As the network contin-
ues to mature, randomized clinical trials and studies of knowl-
edge translation are becoming more common.
 One of the earliest unfunded, but nevertheless important and 
ongoing research studies is the PECARN Core Data Project (PCDP). 
In this observational, epidemiological study, specific data elements 
from all ED visits across all participating PECARN sites are up-
loaded electronically to a central repository annually.4 This PCDP 
database was used for some early research studies, including two 
studies comparing the availability and accuracy of administrative 
versus clinical data elements for pediatric emergency visits.5,6 PCDP 
data were also used to demonstrate differences in ancillary test-
ing (chest radiography and laboratory studies) associated with 
patient, provider, and hospital characteristics among children with 
asthma.7 Additionally, PCDP data were used to develop a consen-
sus-based and clinically sensible diagnosis grouping system. The 
diagnosis grouping system includes 21 groups and 77 subgroups, 
which account for the vast majority of diagnoses among pediat-
ric ED visits.8 Study investigators also developed a diagnosis-based 
severity classification system associated with actual measures of 
ED resource use.9 As PECARN research studies are now more fre-
quently interventional trials, PCDP data continue to be essential 
in providing background data, generating hypotheses, and deter-
mining feasibility of conducting prospective studies, including the 
likelihood of obtaining adequate sample sizes in children with 
specific medical and traumatic conditions.
 PECARN investigators also have performed large, observational 
cohort studies to develop clinical prediction rules for pediatric pa-
tients who have experienced blunt trauma. Using both prospec-
tive cohort and retrospective case-control methodology, investi-
gators attempted to identify pediatric patients who were at low 
risk for severe intracranial, intra-abdominal, and cervical spine 
injuries after blunt trauma and in whom evaluation may be safely 
limited, and radiation from radiography avoided.10-12
 The largest of these studies was a prospective cohort study of 
42,412 children with minor blunt head trauma. Based on data 
from these patients, two clinical prediction rules were derived 
and validated, one for patients <2 years and another for those 2 
years until their 18th birthday. The rules reliably identify patients 
at very low risk of clinically important traumatic brain injuries.10 
Sub-analyses of data from this study demonstrated the likelihood 
of clinically important traumatic brain injury associated with pres-
ence of several isolated individual risk factors.13-16 All of these 
studies and sub-studies provide the evidence to help clinicians 
limit computed tomography (CT) use to only those children at 
non-negligible risk of clinically-important traumatic brain injuries 
after trauma.
 A similarly designed, cohort study of 12,044 children with blunt 
torso trauma resulted in a prediction rule using patient history 
and physical examination findings to identify those at very low 
risk for intra-abdominal injuries requiring acute intervention.11 
Additionally, PECARN performed a large retrospective case-con-
trol study of 540 children with cervical spine injuries from blunt 
trauma, comparing these patients to 2,774 controls. The investi-
gators identified eight factors associated with cervical spine inju-
ries.12 PECARN investigators are planning to pursue further study 
of cervical spine injuries in a prospective fashion with the goal of 
limiting the use of cervical immobilization and radiation in chil-
dren with blunt trauma.
 Another focus area of PECARN research is improving the safety 
of care delivered to children in the ED. In this area, PECARN in-
vestigators performed a research study describing ED characteris-
tics related to and staff perceptions of safety,17 as well as a study 
describing the frequency and characteristics of medication errors 
in pediatric EDs.18 Additionally, PECARN investigators developed 
an infrastructure for reporting and analyzing safety events occur-
ring in EDs throughout the network.19
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 Toward the goals of developing standards and methods for mea-
suring the quality of care delivered in pediatric EDs, one group of 
investigators identified and categorized performance measures 
relevant to pediatric emergency care.20 Another group is complet-
ing analysis in a study to assess the consistency, reliability, and 
validity of a specific assessment tool to evaluate the quality of 
care provided at pediatric ED visits (data analysis ongoing). That 
study is also attempting to identify hospital, ED, physician, and 
patient level factors that influence the quality of care delivered 
to ill and injured children in the ED. Yet another ongoing study 
pertaining to the quality of care delivered in the pediatric ED uses 
the electronic health record, as well as Natural Language Process-
ing, to compare severity-adjusted quality measures of care across 
different institutions. In that study, investigators are using data 
from a registry of electronic medical records at six hospitals with-
in the network.21 This novel “PECARN Registry” is using state-of-
the-art information technology with the goal of providing feed-
back to clinicians regarding their practice patterns and whether 
they are achieving accepted quality metrics in the care of acutely 
ill and injured children.
 As PECARN has matured, it has also demonstrated the ability 
to perform large, randomized clinical trials which seek to provide 
definitive evidence regarding treatment of acutely ill and injured 
children. PECARN’s first randomized controlled trial was a double-
blind comparison of oral dexamethasone versus placebo in infants 
with moderate-to-severe bronchiolitis. This study was conducted 
at 20 PECARN sites and demonstrated no difference between the 
groups in admission rates or respiratory status after four hours of 
observation.22 This high-profile study has been widely referenced 
and hopefully has decreased the inappropriate use of corticoste-
roids in this population. 
 In another large, double-blind, randomized PECARN trial, in-
vestigators demonstrated no improvement in the safety or effica-
cy of intravenous lorazepam over diazepam in the treatment of 
pediatric status epilepticus.23 This study was particularly signifi-
cant because it represented the first pediatric study in the USA 
that was granted Federal Exception from Informed Consent (EFIC) 
for emergency research. Performing a trial under EFIC required 
extensive planning and preparation as each participating hospital 
engaged in a mandatory period of “community consultation” where 
the surrounding public was informed that children presenting to 
the hospital in status epilepticus may be enrolled and randomized 
before the guardians consented for their children to participate in 
the study. Clinical trials performed under EFIC are likely to become 
more frequent in PECARN’s future, as the network tries to address 
more complicated clinical issues under emergent situations. 
 With its experience and large patient populations, PECARN is 
poised to perform trials to definitively answer even more compli-
cated and challenging medical and traumatic controversies. Sev-
eral such trials are ongoing currently. A trial of therapeutic hypo-
thermia after pediatric cardiac arrest seeks to determine if this 
practice, previously studied in adults, should be applied to chil-
dren after cardiopulmonary arrest.24 This study includes children 
who have experienced cardiac arrest, either out-of-hospital or in 
the in-hospital setting. The in-hospital arrest arm of this trial is 
nearing completion; the out-of-hospital arrest arm has already 
completed enrollment. Another ongoing large, complex study of 
acutely ill children is a randomized trial of four different intrave-
nous fluid regimens (using a factorial study design) in children 
with diabetic ketoacidosis. Different rates of administration and 
sodium content of intravenous fluid are being compared to de-
termine any differences in the development of cerebral injury be-
tween treatment groups.25
 PECARN trials also seek to study new therapeutic options for 
emergent conditions in children. A placebo-controlled trial of pro-
biotics to hasten recovery from acute gastroenteritis began pa-
tient enrollment in 2014. With the large burden of diarrheal dis-
ease worldwide, this study has the potential for global impact, 
including in developing nations. Additionally, a randomized, pla-
cebo-controlled study of intravenous magnesium for the treat-
ment of acute pain crisis in children with sickle cell disease con-
cluded patient enrollment very recently.26
 Knowledge translation is a logical next step for many PECARN 
studies, as the network has generated much evidence in the past 
decade, and now strives to improve the delivery of evidence-based 
care in EDs throughout the USA and around the world. One re-
cent study investigated whether embedding the PECARN trau-
matic brain injury prediction rule10 into the electronic health re-
cord would decrease the frequency of unnecessary CT imaging in 
patients at very low risk for clinically important traumatic brain 
injuries.27 Enrollment in this study is complete and data analysis 
is under way. The results of this project are one step in helping 
PECARN achieve its goal of developing robust systems of study-
ing the translation of evidence into practice. This is a particularly 
important goal as the network nears completion of several defini-
tive trials for the care of acutely ill and injured children.
 PECARN is also working on research studies evaluating cut-
ting-edge technologies. One PECARN study is assessing new di-
agnostic techniques to evaluate febrile infants younger than 60 
days of age. This study analyzes ribonucleic acid (RNA) expression 
of blood leukocytes (transcriptional “biosignatures”) in these young 
infants’ host-responses to bacterial infections. Initial analyses 
suggest that these new microarray techniques will allow discrim-
ination between febrile infants with and without culture proven 
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bacterial infections with excellent accuracy.28,29 With refinement, 
these techniques may eventually challenge the reference stan-
dard of bacterial culture for diagnosing serious bacterial infec-
tions in young febrile infants.
 Current and future PECARN studies harness the screening po-
tential of the ED in the study of pediatric and adolescent health 
issues. An ongoing study seeks to determine if a brief, two-ques-
tion screen can accurately detect alcohol use and alcohol-related 
problems in adolescents. Additionally, an upcoming study of ado-
lescents in the ED will attempt to prospectively determine an op-
timal suicide risk screening strategy and an algorithm to triage 
these adolescents for immediate care or follow-up based on their 
risk stratification. 
 In recent years, PECARN has also engaged in new international 
collaborations, contributing as a member of Pediatric Emergency 
Research Networks (PERN)30,31 PERN’s initial research study was 
published in 2013 and identified clinical and patient history fac-
tors for severe outcomes in children with H1N1 influenza infec-
tions.32 Ongoing studies with PERN include a prospective, multi-
center study to determine the epidemiology and management 
differences of acute poisonings in children in eight different re-
gions of the world33 and a study of the association of pharmaco-
therapy and outcomes in infants presenting to the ED with acute 
bronchiolitis. 
CHALLENGES AND BENEFITS OF PECARN 
RESEARCH
Although PECARN has overcome many of the barriers to perform-
ing ED network research and performed many successful research 
studies, some challenges to the network and its investigators per-
sist. The substantial size of multicenter studies can make them 
unwieldy and difficult to fund and perform. In order to ensure 
uniform implementation of protocols and collection of high qual-
ity data, study investigators must invest in extensive initial and 
continuing training of study personnel. Additionally, investigators 
must develop an explicit protocol and manual of operations de-
scribing standardized study procedures for all sites, and must mon-
itor regularly for correct implementation. Initiating a study at 
multiple sites is time consuming and requires an initial face-to-
face meeting of many investigators, as well as ongoing meetings 
either electronically or in person. Secure and timely transmission 
of data from study sites to the lead site and/or the data-coordi-
nating center must be established. In PECARN, all studies must be 
reviewed and approved by the local Institutional Review Board 
(IRB) or ethics committee at each study site. IRBs have varying 
standards, which often result in multiple modifications to a study 
protocol before its approval across all participating sites. For this 
and other reasons, development and implementation of a cen-
tralized IRB is a long-term goal of PECARN.34 Once a study is un-
derway, ongoing monitoring of study data, protocol implementa-
tion processes, and regulatory documentation are performed ei-
ther remotely or by trained personnel who travel to individual 
sites. We are currently evaluating a process of virtual monitoring 
of study sites remotely via access to the electronic health record 
in order to enhance efficiencies, and decrease costs.
 A notable challenge which PECARN faces is obtaining adequate 
funding for studies. Because network multicenter studies are fre-
quently expensive compared to single institution studies, the amo-
unt of funding required to perform them frequently exceeds the 
standard limit of many funding agencies. In an era when only a 
small percentage of federal grant applications for clinical research 
in the USA are successfully funded, the necessity of exceeding es-
tablished funding caps can further challenge the ability of investi-
gators to obtain funding. Moving forward, large networks like PE-
CARN must be creative and diverse in seeking funding for research. 
 Even with these challenges, multicenter research within PECA-
RN has many benefits for investigators. The network provides a 
clinical laboratory in which large-scale studies can be perform ed. 
Often, small, pilot research studies suggest a benefit of a new prac-
tice or medication, and PECARN then provides the opportunity to 
test the study results by conducting large-scale, definitive, and 
potentially practice-changing research. Performing a study within 
a network with an established reputation for performing and pub-
lishing high-quality studies may increase an investigator’s chance 
of successfully obtaining grant funding, offsetting some of the 
funding challenges of research conducted outside of such a net-
work. PECARN investigators also play a role in shaping the future 
of pediatric emergency medicine (PEM) by providing crucial lead-
ership and mentorship to the next generation of PEM investigators.
 Young investigators involved in PECARN studies directly bene-
fit from senior mentorship and exposure to the network’s research 
process. Serving as a co-investigator or as a site PI for a PECARN 
study provides an introduction to the research process as well as 
insight into the challenges and benefits of multicenter research. 
Involvement as a site PI on a multicenter study also offers author-
ship opportunities, including opportunities to be a supporting au-
thor on the study’s main manuscript or the primary author on a 
planned secondary analysis. 
 In recent years, PECARN has made concentrated efforts to fo-
cus on mentorship and development of future investigators. These 
efforts include inviting junior investigators to observe the process 
at network steering committee meetings. This allows them to view 
and participate in study proposal development and provides them 
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access to the mentorship and guidance of experienced investiga-
tors. Specific training sessions are held annually during which ju-
nior investigators present their research concepts for constructive 
review by senior PECARN investigators, many of whom are con-
tent experts as well as seasoned researchers who have conducted 
one or more large multicenter studies. If a junior investigator’s 
research concept is accepted for review by the PECARN steering 
committee, he or she also benefits from the feedback of experi-
enced statisticians and epidemiologists at our independent data 
coordinating center.
 Participation in a research network also provides benefits at an 
institutional level. Participation in PECARN fosters development 
and growth of a solid research program at local institutions by 
helping to instill a culture of research (particularly in multicenter/
collaborative research) and by providing specific infrastructure in 
the form of support for research and study coordinators. Each 
study-specific grant provides additional funding for each partici-
pating institution.
FUTURE DIRECTIONS
PECARN has evolved substantially since its inception in 2001, with 
progression from retrospective epidemiologic studies to prospec-
tive observational studies and then to interventional trials and 
implementation research. As it moves into the future, PECARN 
will continue to pursue its mission of performing high-quality 
and definitive research in the prevention and treatment of acute 
illnesses and injuries in children. It is critical that evidence gener-
ated by PECARN research be disseminated, implemented, and in-
corporated into the care of children in various acute care settings. 
In partnership with EMSC, PECARN strives to be a leader in PEM 
in each step of this continuum. Through leadership, mentorship, 
and development of new and junior investigators, PECARN hopes 
to ensure the continuation of high-quality PEM research over time. 
Finally, through increased and broadening collaboration both na-
tionally and internationally, PECARN will continue to generate and 
widely disseminate new evidence in the care of acutely ill and in-
jured children.
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